Clinical trial
Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in…
NCT00241358 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00241358 |
|---|---|
| Title | Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies |
| Official title | A Phase I/II Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients With Advanced Hematological Malignancies |
| Lead sponsor | Washington University School of Medicine, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Myeloid, Acute, Myelogenous, Chronic, Lymphoblastic, Lymphocytic Leukemia, Myelodysplastic Syndromes, Multiple Myeloma, Lymphoma and 2 more |
| Intervention type | Drug, Procedure |
| Interventions | AMD3100, Stem Cell Transplant |
| Enrollment | 92 |
| Start date | May 1, 2004 |
| Primary completion | Dec 1, 2009 |
| Completion | Feb 1, 2010 |
| First posted | Oct 18, 2005 |
| Last update posted | Jun 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: